FDA
-
A drug used to treat asthma has been shown to substantially reduce the risk of potentially life-threatening reactions in people aged one and older with multiple common food allergies, including peanuts, following accidental exposure.
-
The FDA has granted clearance to the first AI-powered medical device to assist physicians in detecting all 3 common skin cancers. Providing a more accurate way of identifying skin cancer will enable patients to access necessary treatment more quickly.
-
The FDA has approved the first cell-based gene therapies for treating sickle cell disease, one of which is the first approved therapy to utilize the CRISPR/Cas9 gene editing technology. It signals advancements in gene therapy and regenerative medicine.
-
The US has officially got a homegrown hero in the burgeoning global industry of effective weight-loss treatment, with the FDA approval of Lilly’s Zepbound. The company has revealed its cost, dosages, insurance subsidies and when it will be on shelves.
-
With an industry expected to be worth US$100 billion by 2030, a supply crisis, slow manufacturing processes, and a high price tag, it's no surprise the much-hyped class of injectable weight-loss drugs has become a prime target for counterfeit trade.
-
Adding weight to the large body of scientific evidence that has found phenylephrine is as useless as a placebo for nasal congestion, an advisory panel has declared common oral medications ineffective and urged for them to be removed from sale.
-
The US Food and Drug Administration recently fast-tracked its approval of brexpiprazole (Rexulti), an antipsychotic for treating agitation in dementia patients, when clinical studies demonstrated an increased risk of death and no meaningful benefit.
-
A debate has raged for decades as to whether a common artificial sweetener, aspartame, causes cancer. While the World Health Organization has now said it 'possibly' does, experts argue there's little evidence to support this and that it's still safe.
-
The first Alzheimer’s disease medication shown in trials to slow progression of the disease by 27% has been given full approval by the Food and Drug Administration, paving the way for its costly price tag to be covered by Medicare.
-
The FDA has approved a new drug for patients in the early-stages of Alzheimer's disease but growing concerns over its safety and real-world efficacy have led to division amongst researchers, with some suggesting it should not be authorized for wide use.
-
The US Food and Drug Administration (FDA) has approved the first drug that can delay the onset of type 1 diabetes. A recent trial has shown that the drug, named teplizumab, can give patients several extra disease-free years.
-
The FDA has given California company Upside Foods the green light for its lab-grown chicken, paving the way for it to reach market shelves next year, and making the US the second country in the world to allow legal sales of lab-grown meat products.
Load More